Welcome Guest
Sign In
Register
Home
API
Manufacturing
Clinical Trials
Analytical Testing
Cold Chain
Articles
Facility Tours
News
Events
Videos
Clinical Trials Documentary
A Solid Dosage Future Documentary
Whitepapers/App Notes
Issue Archives
Company Focus
Service Directory
Register
Sign In
Home
API
Product and Service Directory
Clinical Trial Development Services and Outsourcing
Contract Research Organizations / Contract Research Services (CRO Services)
Preclinical Contract Research / Preclinical Research Services (Preclinical CRO)
Preclinical Pharmacology Services
Preclinical Pharmacology Services
Preclinical Pharmacology Services
Preclinical Drug Efficacy Testing and Modeling Services
Preclinical Pharmaceutical Screening Services
Preclinical Pharmacology Services by Therapy Type
Preclinical Cancer Pharmacology / Oncology Pharmacology Services
Preclinical Cardiovascular Pharmacology Services
Preclinical Diabetes Pharmacology Services
Preclinical Inflammation Pharmacology Services
Preclinical Multiple Sclerosis Pharmacology Services
News
Minaris Enhances GMP Cell Banking Suites at Philadelphia Facility
Thursday, June 18, 2026
Minaris announced the enhancement of its dedicated GMP cell banking suites at its Philadelphia facility, a centralized hub for cell banking and biosafety testing.
read more
Alcami Expands Quality, Packaging, and Storage Capabilities at Tennessee Facility
Thursday, June 18, 2026
Alcami Corporation announced a series of strategic and operational investments at its Tennessee facility, which was recently added to the company’s network through its acquisition of Tjoapack.
read more
WuXi Biologics' Suzhou Biosafety Testing Center Receives Fourth EMA GMP Certification
Thursday, June 18, 2026
WuXi Biologics announced that its Biosafety Testing Center in Suzhou has successfully passed a Good Manufacturing Practice (GMP) inspection by the European Medicines Agency (EMA) with zero critical findings.
read more
Mabion Reactivates MabionCD20 Through Rare Disease Collaboration with Oddifact
Thursday, June 18, 2026
Mabion S.A., a Polish biotechnology company, has signed a letter of intent (LoI) with French TechDev company Oddifact SAS to evaluate and advance MabionCD20 for potential use in rare diseases.
read more
CCRM, OmniaBio and Avectas Partner to Improve Cell Therapy Manufacturing
Tuesday, June 16, 2026
CCRM and its CDMO subsidiary OmniaBio announced an agreement with Avectas Limited to evaluate its automated, integrated and scalable cell therapy manufacturing platform.
read more
More News
Featured Videos
A Solid Dosage Future
In the pharmaceutical manufacturing space, while biopharmaceuticals often dominate discussions, it's crucial to acknowledge the enduring significance of solid dosage products (e.g., tablets, capsules, pills). These traditional forms remain the ...
Pharma Flash - Biopharm Facility News and Regulatory Updates in this Week’s ...
Check out the top pharma news of the week from our Editor-In-Chief, Mike Auerbach. Watch video: Eli Lilly Chooses Vendor for Single-Use Facility and FDA Approves OTC oral contraceptive plus more news in this week’s Pharma Flash
More Videos
Featured Products and Services
We're sorry, no matching articles were found. Please select different filter options and try your search again.
More Featured Products
Featured Articles
We're sorry, no matching articles were found. Please select different filter options and try your search again.
Subscriptions
Get started here for your complimentary print or digital subscription
Sign up Now »